المؤلفون: 林紀佑, 陳炯年, 黃妙慈, 李士傑, 張正琪, 李心予, LIN, CHI-IOU, CHEN, CHIUNG-NIEN, HUANG, MIAO-TZU, LEE, SHYH-JYE, CHANG, CHENG-CHI, LEE, HSIN-YU

المساهمون: 外科

مصطلحات موضوعية: lysophosphatidic acid (LPA), vascular endothelial growth factor-C (VEGF-C), nuclear factor kappaB (NF-kappa B), endothelial growth factor receptor (EGFR) transactivation, endothelial cells, cyclooxygenase-2 (COX-2)

العلاقة: CELLULAR SIGNALLING v.20 n.10 pp.1804-1814; http://ntur.lib.ntu.edu.tw/handle/246246/174650Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/174650Test

المؤلفون: 戴仰霞, Dai, Yang-Shia

المساهمون: 余幸司, 臺灣大學：臨床醫學研究所

مصطلحات موضوعية: 嬰兒型血管瘤, 第一型葡萄糖運輸蛋白, 鹼性纖維母細胞生長因子, 血管內皮細胞生長因子, 免疫組織化學染色法, 蛋白質基因產物9.5, 酪胺酸羥化酶, 活化凋亡蛋白3, 交感神經, hemangioma of infancy, glucose transporter I, basic fibroblast growth factor, vascular endothelial growth factor, immunohistochemistry, protein gene product 9.5, tyrosine hydroxylase, activated caspase 3, sympathetic nerve

وصف الملف: 1955027 bytes; application/pdf

العلاقة: Adegboyega PA, Qiu S. Hemangioma versus vascular malformation: presence of nerve bundle is a diagnostic clue for vascular malformation. Arch Pathol Lab Med. 2005; 129:772-5. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac Donald D, Folkman J, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J pediatr. 1998; 132:527-30. Barnes CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A. 2005; 102:19097-102. Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther. 2005; 18:151-9. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomized controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002; 17: 360:521-7. Berard M, Sordello S, Ortega N, Carrier JL, Peyri N, Wassef M, et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol. 1997; 150:1315-26. Berg JN, Walter JW, Thisanagayam U, Evans M, Blei F, Waner M, et al. Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation? J Clin Pathol. 2001; 54:249–52. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol. 1999; 14: 401-8. Boehm DK, Kobrinsky NL. Treatment of cavernous hemangioma with vincristine. Ann Pharmacother. 1993; 27:981. Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol. 1960; 82:667-80. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest. 2001; 107:745-52. Carmeliet P. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet. 2003; 4:710-720. Chan YC, Giam YC. Guidelines of care for cutaneous haemangiomas. Ann Acad Med Singapore. 2005; 34:117-23. Chen D, Lin XX, Li W. The relationship between the expression of HIF-1alpha and the angiogenesis in infancy hemangioma. Zhonghua Zheng Xing Wai Ke Za Zhi. 2005; 21:115-8. Cheng L, Liang J, Tang S. The study on the role of apoptosis suppressive gene bcl-2 in the pathogenesis of hemangioma. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1999; 15:35-6. Chlenski A, Liu S, Crawford SE, Volpert OV, DeVries GH, Evangelista A, et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Res. 2002; 62:7357-63. Crawford SE, Stellmach V, Ranalli M, Huang X, Huang L, Volpert O, et al. Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci. 2001; 114:4421-8. Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangi- omas are arrested in an early developmental vascular differentiation state. Mod Pathol. 2004; 17:1068-79. Dosanjh A, Chang J, Bresnick S, Zhou L, Reinisch J, Longaker M, et al. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells. J Cutan Pathol. 2000; 27:441-50. Dosquet C, Coudert MC, Wassef M, Enjolras O, Drouet L. Importance of bFGF (basic fibroblast growth factor) for diagnosis and treatment of hemangiomas. Ann Dermatol Venereol. 1998; 125:313-6. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999; 341:173-81. Dubois J, Hershon L, Carmant L, Belanger S, Leclerc JM, David M. Toxicity profile of interferon alpha-2b in children: a prospective evaluation. J pediatr. 1999; 135:782-5. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001; 107:1647-54. Garmendia G, Miranda N, Borroso S, Longchong M, Martinez E, Ferrero J, et al. Regression of infancy hemangiomas with recombinant IFN-alpha 2b. J Interferon Cytokine Res. 2001; 21:31-8. Garzon MC, Lucky AW, Hawrot A, Frieden IJ. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol. 2005; 52:281-6. Hazen PG, Carney JF, Engstrom CW, Turgeon KL, Reep MD, Tanphaichitr A. Proliferating hemangioma of Infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol. 2005; 22:254-6. Hlmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr. 1955; 44:370-9. Honma Y, Araki T, Gianino S, Bruce A, Heuckeroth R, Johnson E, et al. Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron. 2002; 35:267-82. Huang D, Rutkowski JL, Brodeur GM, Chou PM, Kwiatkowski JL, Babbo A, et al. Schwann cell-conditioned medium inhibits angiogenesis in vitro and in vivo. Med Pediatr Oncol. 2000; 35:590-2. Huang D, Rutkowski JL, Brodeur GM, Chou PM, Kwiatkowski JL, Babbo A, et al. Schwann cell-conditioned medium inhibits angiogenesis. Cancer Res. 2000; 60:5966-71. Illum N, Karlsmark T, Svejgaard E, Ullman S, Yssing M. Ulcerated haemangi- oma successfully treated with interferon alfa-2b and topical granulocyte- macrophage colony-stimulating factor. Dermatology. 1995; 191:315-7. Jang YC, Isik FF, Gibran NS. Nerve distribution in hemangiomas depends on the proliferative state of the microvasculature. J Surg Res. 2000; 93:144-8. Jiang XW, Wang GH, Li JH, Chen ZX, He F. Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations. Chin Med J. 2005; 118:977-81. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al. Mutations in the activin receptor−like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996; 13:189-95. Leon-villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plas Surg. 2005; 58:348-52. Lopez-Gutierrez JC, Diaz M, Ros Z. Giant rapidly involuting congenital hemangioma of the face. Arch Facial Past Surg. 2005; 7:316-8. Mukouyama YS, Gerber HP, Ferrara N, Gu C, Anderson DJ. Peripheral nerve- derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development. 2005; 132:941-52. Mulliken JB. Diagnosis and natural history of hemangiomas. In: Mulliken JB, Young AE, editors. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: WB Saunders; 1988. p. 41. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000; 37:517-84. Nguyen VA, Furhapter C Romani N, Weber F, Sepp N. Infantile hemangioma is a proliferation of β4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol. 2004; 35:739-44. North PE, Waner M, Mizeracki A, Mihm MC. GLUT-1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000; 31:11-22. North PE, Waner M, Mizeracki A, Mark RE, Nicholas R, Kincannon J, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001; 137:559-70. Perez PJ, Pardo MJ, Gomez BC. Treatment of life-threatening infantile hemangiomas with vincristine. N Eng J Med. 1995; 333:69. Rampini E, Rampini P, Occella C, Bleidl D. Interferon alpha 2b for treatment of complex cutaneous haemangiomas of infancy: a reduced dosage schedule. Br J Dermatol. 2000; 142:189-91. Razon MJ, Kraling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998; 5:189-95. Reilly DM, Ferdinando D, Johnston, Shaw C, Buchanan KD, Green MR. The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations. Br J Dermatol. 1997; 137:63-70. Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A. 2002; 99:7455-60. Ritter MR, Moreno SK, Dorrell MI, Rubens, Ney J, Friedlander DF, et al. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase during involution. Lymphat Res Biol. 2003; 1: 291-9. Sidbury R, Neuschler N, Neuschler E, Sun P, Sun P, Wang XQ, et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J invest Dermatol. 2003; 121:1205-9. Smoller BR, Rosen S. Port-wine stains. A disease of altered neural modulation of blood vessels? Arch Dermatol. 1986; 22:177-9. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994; 93:2357-64. Takikawa O, Yoshida R, Kido R, Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J Biol Chem. 1986; 261:3648-53. Tamayo L, Ortiz DM, Orozco-Covarrubias L, Duran-McKinster C, Mora MA. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. Arch Dermatol. 1997; 133:1567-71. Turner C, Gross S. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. AM J Pediatr Hematol Oncol. 1994; 16:325-8. Vikkula M, Boon LM, Carraway KL, Calvert JT, Diamonti AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996; 87:1181-90. Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JW, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer. 2002; 33:295-303. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC . The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003; 139:869-75. Welsh O, Olazaran Z, Gomez M, Salas J, Berman B. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol. 2004; 51:639-42. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol. 2001; 159:2271-80. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood. 2004; 103:1373-5. Yu Y, Wylie-Sears J, Boscolo E, Mulliken JB, Bischoff J. Genomic Imprinting of IGF2 is maintained in Infantile Hemangioma despite its High Level of Expression. Mol Med. 2005 1; [Epub ahead of print] Zvulunov A, Metzker A. Hemangiomas and vascular malformations: Unapproved treatments. Clin Dermatol. 2002; 20:660-7.; zh-TW; http://ntur.lib.ntu.edu.tw/handle/246246/55572Test; http://ntur.lib.ntu.edu.tw/bitstream/246246/55572/1/ntu-95-P92421012-1.pdfTest

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/55572Test
http://ntur.lib.ntu.edu.tw/bitstream/246246/55572/1/ntu-95-P92421012-1.pdfTest

المؤلفون: 黃瑞仁, 吳寬墩, 蔡宜蓉, 吳允升, 林彥宏, HWANG, JUEY-JEN, WU, KWAN-DUN, TSAI, I- JUNG, WU, VIN-CENT, LIN, YEN-HUNG

المساهمون: 內科

مصطلحات موضوعية: chronic kidney disease stage 5, haplotypes, polymorphisms, progressive renal disease, transforming growth factor beta-1, vascular endothelial growth factor

العلاقة: NEPHROLOGY DIALYSIS TRANSPLANTATION v.20 n.11 pp.2579-2580; http://ntur.lib.ntu.edu.tw/handle/246246/93065Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/93065Test

المؤلفون: 鄭積慧, 曹永魁, 蔡宜蓉, CHENG, CHI-HUI, TSAU, YONG-KWEI, TSAI, I- JUNG

المساهمون: 小兒科

مصطلحات موضوعية: nephromegaly, biliary atresia, liver transplantation, hepatoblastoma, hepatocyte growth factor, transforming growth factor beta 1

العلاقة: AMERICAN JOURNAL OF KIDNEY DISEASES v.46 n.5 pp.830-836; http://ntur.lib.ntu.edu.tw/handle/246246/92605Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/92605Test

المؤلفون: 曹永魁, 盧孟佑, 倪衍玄, TSAU, YONG-KWEI, LU, MENG-YAO, NI, YEN- HSUAN

المساهمون: 小兒科

مصطلحات موضوعية: nephromegaly, biliary atresia, fulminant hepatitis, hepatocyte growth factor (HGF), transforming growth factor-beta (TGF- beta), EPITHELIAL-CELL HYPERTROPHY

العلاقة: AMERICAN JOURNAL OF KIDNEY DISEASES v.38 n.2 pp.279-285; http://ntur.lib.ntu.edu.tw/handle/246246/94828Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/94828Test

المؤلفون: 楊為舜, 蔡敦仁, 石崇良, 黃政文, 莊雪芳, 陳孟涵, 方震中, YANG, WEI-SHUN, TSAI, TUN-JEN, SHIH, CHUNG-LIANG, HUANG, JENQ-WEN, CHUANG, HSUEH-FANG, CHEN, MENG-HAN, FANG, CHENG-CHUNG

المساهمون: 內科

مصطلحات موضوعية: Interleukin-6, Peritoneal dialysis, Ultrafiltration, Vascular endothelial growth factor-C

العلاقة: BLOOD PURIFICATION v.28 n.1 pp.69-74; http://ntur.lib.ntu.edu.tw/handle/246246/188624Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/188624Test

المؤلفون: 戴岑芳, 陳朝寶, 林秋君, 陳令儀, 鄭景暉, 張美姬, TAI, TSENG-FANG, CHAN, CHIU-PO, LIN, CHIU -CHUN, CHEN, LIN-I, JENG, JIIANG-HUEI, CHANG, MEI-CHI

المساهمون: 牙醫學系所

مصطلحات موضوعية: alkaline phosphatase, cell growth, dental pulp, differentiation, signaling, Smad, transforming growth factor beta

العلاقة: JOURNAL OF ENDODONTICS v.34 n.4 pp.427-432; http://ntur.lib.ntu.edu.tw/handle/246246/174599Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/174599Test

المؤلفون: 陳燕玲, 劉如濟, 羅時鴻, 陳正憲, 洪傳岳, 陳錦澤, 鄭志鴻, CHEN, YEN-LING, LIU, JU-CHI, LOH, SHIH- HURNG, CHEN, CHENG-HSIEN, HONG, CHUANG-YE, CHEN, JIN-JER, CHENG, TZU-HURNG, CHEN, JIN- JER

المساهمون: 內科

مصطلحات موضوعية: urotensin II, extracellular signal-regulated kinase, epidermal growth factor receptor, rat cardiac fibroblasts

العلاقة: EUROPEAN JOURNAL OF PHARMACOLOGY v.593 n.1-3 pp.24-29; http://ntur.lib.ntu.edu.tw/handle/246246/174540Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/174540Test

المؤلفون: 李聰明, 陳建璋, 林美淑, 張念中, LEE, TSUNG-MING, CHEN CHIEN-CHANG, LIN MEI-SHU, CHANG NEN-CHUNG

المساهمون: 內科

مصطلحات موضوعية: myocardial infarction, nerve growth factor, rats, sympathetic reinnervation

العلاقة: AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY v.294 n .4 pp.H1871-H1879; http://ntur.lib.ntu.edu.tw/handle/246246/174526Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/174526Test

المؤلفون: 王怡人, 謝武勳, 郭育良, 紀秀華, 謝佳容, 黃耀輝, 陳保中, WANG, I-JEN, HSIEH, WU-SHIUN, GUO, YUE- LIANG, JEE, SHIOU-HWA, HSIEH, CHIA-JUNG, HWANG, YAW-HUEI, CHEN, PAU-CHUNG

المساهمون: 小兒科

مصطلحات موضوعية: atopic dermatitis, intrinsic, maternal stress, nerve growth factor

العلاقة: CLINICAL AND EXPERIMENTAL ALLERGY v.38 n.8 pp.1302-1308; http://ntur.lib.ntu.edu.tw/handle/246246/186793Test

الإتاحة: http://ntur.lib.ntu.edu.tw/handle/246246/186793Test